Exploring anti-IL6 receptor monoclonal antibody tocilizumab in neuromyelitis optica

被引：0
|
作者：
Araki, M. [1 ]
Matsuoka, T. [1 ]
Aranami, T. [1 ]
Nakamura, M. [1 ]
Okamoto, T. [1 ]
Murata, M. [1 ]
Miyake, S. [1 ]
Yamamura, T. [1 ]
机构：
[1] Natl Ctr Neurol & Psychiat, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：326 / 327
页数：2
相关论文
共 50 条
  • [21] ANTI-IL-6 RECEPTOR ANTIBODY (TOCILIZUMAB): A B CELL TARGETING THERAPY
    Snir, A.
    Kessel, A.
    Haj, T.
    Rosner, I
    Rozenbaum, M.
    Slobodin, G.
    Toubi, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70
  • [22] ANTI-IL-6 RECEPTOR ANTIBODY (TOCILIZUMAB): A B CELL TARGETING THERAPY
    Toubi, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 152 - 152
  • [23] Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy
    Snir, A.
    Kessel, A.
    Haj, T.
    Rosner, I.
    Slobodin, G.
    Toubi, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 697 - 700
  • [24] The effect of Neuromyelitis optica (NMO)-IgG and anti-IL-6 receptor monoclonal antibody (SA237; satralizumab) for barrier function at the Blood-Brain Barrier in vitro
    Takeshita, Y.
    Serizawa, K.
    Fujikawa, S.
    Shimizu, F.
    Maeda, T.
    Sano, Y.
    Koga, M.
    Kanda, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 208 - 209
  • [25] Intracellular Dynamics and Fate of a Humanized Anti-Interleukin-6 Receptor Monoclonal Antibody, Tocilizumab
    Fujimoto, Keiko
    Ida, Hiroaki
    Hirota, Yuko
    Ishigai, Masaki
    Amano, Jun
    Tanaka, Yoshitaka
    MOLECULAR PHARMACOLOGY, 2015, 88 (04) : 660 - 675
  • [26] Treatment Resistant Neuromyelitis Optica Responsive to Anti IL-6 Immunotherapy
    Siwoski, Mark-Victor
    Lynch, Sharon G.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 120 - 120
  • [27] Long-term safety and efficacy of tocilizumab (an anti-IL-6 receptor monoclonal antibody) in monotherapy, in patients with rheumatoid arthritis
    Nishimoto, N.
    Miyasaka, N.
    Yamamoto, K.
    Kawai, S.
    Takeuchi, T.
    Azuma, J.
    Kishimoto, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 122 - 122
  • [28] Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
    Imagawa, Tomoyuki
    Yokota, Shumpei
    Mori, Masaaki
    Miyamae, Takako
    Takei, Syuji
    Imanaka, Hiroyuki
    Nerome, Yasuhito
    Iwata, Naomi
    Murata, Takuji
    Miyoshi, Mari
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 109 - 115
  • [29] Anti-IL-6 receptor monoclonal antibody as a new treatment of endometriosis
    Ahmed A. El-Zayadi
    Sara A. Mohamed
    Mohammad Arafa
    Shereen M. Mohammed
    Abdelhady Zayed
    Mohamed S. Abdelhafez
    Ahmed M. Badawy
    Immunologic Research, 2020, 68 : 389 - 397
  • [30] Anti-IL-6 receptor monoclonal antibody as a new treatment of endometriosis
    El-Zayadi, Ahmed A.
    Mohamed, Sara A.
    Arafa, Mohammad
    Mohammed, Shereen M.
    Zayed, Abdelhady
    Abdelhafez, Mohamed S.
    Badawy, Ahmed M.
    IMMUNOLOGIC RESEARCH, 2020, 68 (06) : 389 - 397
12345